BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Efficacy of tricyclic antidepressants in irritable bowel syndrome: A meta-analysis. World J Gastroenterol 2009; 15(13): 1548-1553 [PMID: 19340896 DOI: 10.3748/wjg.15.1548]
URL: https://www.wjgnet.com/1007-9327/full/v15/i13/1548.htm
Number Citing Articles
1
Yang Chen, Li Li, Guo-Qiang Zhang, Rong Xu. Phenome-driven disease genetics prediction toward drug discovery. Bioinformatics 2015; 31(12) doi: 10.1093/bioinformatics/btv245
2
Raghad Alhajaji, Manal Alfahmi, Eatedal Mohammed Alshareef, Alaa Mohammad Kadah Salim, Alshaymaa Khalid Mofareh, Sara Bandar Badirah, Ghosoon Mohammed Bafaraj, Sultan AlDhabei. Does amitriptyline help for irritable bowel syndrome pain management?: An updated systematic review and meta-analysis. Medicine 2026; 105(1) doi: 10.1097/MD.0000000000046869
3
Spyros Peppas, Claudia Pansieri, Daniele Piovani, Silvio Danese, Laurent Peyrin-Biroulet, Andreas G. Tsantes, Enrico Brunetta, Argirios E. Tsantes, Stefanos Bonovas. The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases. Journal of Clinical Medicine 2021; 10(3) doi: 10.3390/jcm10030377
4
Padide Derakhshande, Seyed Jafar Navabi, Yalda Shokoohinia, Hojjat Rouhi-Broujeni, Fateme Deris, Leila Behbood, Foroud Shahbazi, Mahtab Amiri, Mohammad Hosein Farzaei. Efficacy and safety of Achillea wilhelmsii C. Koch capsules on symptom severity and quality of life in patients with irritable bowel syndrome: a randomized, placebo-controlled clinical trial. Journal of Complementary and Integrative Medicine 2019; 16(4) doi: 10.1515/jcim-2018-0123
5
Lisa Ruepert, A Otto Quartero, Niek J de Wit, Geert J van der Heijden, Gregory Rubin, Jean WM Muris. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2011; 2013(3) doi: 10.1002/14651858.CD003460.pub3
6
Longtu Chen, Sheikh J. Ilham, Bin Feng. Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article. Anesthesiology and Pain Medicine 2017; 7(2) doi: 10.5812/aapm.42747
7
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi. An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Metabolism & Toxicology 2020; 16(7) doi: 10.1080/17425255.2020.1767067
8
Michael Camilleri, Emeran A. Mayer. Developing Irritable Bowel Syndrome Guidelines Through Meta-analyses: Does the Emperor Really Have New Clothes?. Gastroenterology 2009; 137(3) doi: 10.1053/j.gastro.2009.07.030
9
Lindsay D. Clendaniel, Paul E. Hyman, John C. Courtney. Pediatricians and Pharmacologically Trained Psychologists. 2011;  doi: 10.1007/978-1-4419-7780-9_12
10
Lucia Carmela Passacatini, Sara Ilari, Saverio Nucera, Federica Scarano, Roberta Macrì, Rosamaria Caminiti, Maria Serra, Francesca Oppedisano, Jessica Maiuolo, Ernesto Palma, Valentina Malafoglia, Carlo Tomino, Massimo Fini, Vincenzo Mollace, Carolina Muscoli. Multiple Aspects of Irritable Bowel Syndrome and the Role of the Immune System: An Overview of Systematic Reviews with a Focus on Polyphenols. International Journal of Molecular Sciences 2024; 25(22) doi: 10.3390/ijms252211993
11
Andreas Schröder, Per Fink. Functional Somatic Syndromes and Somatoform Disorders in Special Psychosomatic Units: Organizational Aspects and Evidence-Based Treatment. Psychiatric Clinics of North America 2011; 34(3) doi: 10.1016/j.psc.2011.05.008
12
Yaoyao Lu, Meng Chen, Zhiyin Huang, Chengwei Tang, John Green. Antidepressants in the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis. PLOS ONE 2016; 11(6) doi: 10.1371/journal.pone.0157798
13
Colin M. Smith, Paul B. Hicks, Jon K. Lindefjeld, Benjamin M. Taylor, Daniel R. Fisher, John J. Faragon, Sherrell T. Lam, Luis F. Pereira, Kelly L. Cozza. HIV Psychiatry. 2022;  doi: 10.1007/978-3-030-80665-1_17
14
Michael Stephan, Matthias Karst, Michael Bernateck. Medikamentöse Behandlungsstrategien bei chronischen Schmerzen. PSYCH up2date 2014; 8(01) doi: 10.1055/s-0033-1359999
15
Beena Nair. Handbook of Consultation-Liaison Psychiatry. 2015;  doi: 10.1007/978-3-319-11005-9_8
16
Miguel Saps, Adrian Miranda. Gastrointestinal Pharmacology. Handbook of Experimental Pharmacology 2017; 239 doi: 10.1007/164_2016_119
17
Richard G. Boles, Essam A. Zaki, Jonathan R. Kerr, Kingshuk Das, Sawona Biswas, Ann Gardner. Increased prevalence of two mitochondrial DNA polymorphisms in functional disease: Are we describing different parts of an energy-depleted elephant?. Mitochondrion 2015; 23 doi: 10.1016/j.mito.2015.04.005
18
Antonina Mikocka-Walus, Alexander C. Ford, Douglas A. Drossman. Antidepressants in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology 2020; 17(3) doi: 10.1038/s41575-019-0259-y
19
20
Albert Orock, Tian Yuan, Beverley Greenwood-Van Meerveld. Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance. Frontiers in Pain Research 2021; 1 doi: 10.3389/fpain.2020.609292
21
Stacey B. Gramann, Nancy Byatt. The Evidence-Based Guide to Antidepressant Medications. 2011;  doi: 10.1176/appi.books.9781615378166.lg09
22
Julie R. Price, Alric D. Hawkins, Michael L. Adams, William S. Breitbart, Steven D. Passik. Oxford Textbook of Palliative Medicine. 2015;  doi: 10.1093/med/9780199656097.003.0911
23
Andrew Chang, Janice Oh, Andrea Shin, Megan Oser, Natalie Manitius, Amir Ghaffari, Berkeley N. Limketkai. Similar Symptoms, Distinct Syndromes: Multi-modal Approach to the Patient with an IBD-IBS Overlap. Digestive Diseases and Sciences 2026; 71(3) doi: 10.1007/s10620-025-09473-2
24
Alice Sandberg‐Janzon, Pontus Karling. Drug Survival of Drugs Recommended for Irritable Bowel Syndrome: A Retrospective Observational Study. Neurogastroenterology & Motility 2025; 37(10) doi: 10.1111/nmo.70063
25
Dan HU, Ming-fei KANG, Jun XIONG, Peng DENG. Irritable bowel syndrome with diarrhea (IBS-D) treated with moxibustion on heat-sensitive acupoints: a randomized controlled trial. World Journal of Acupuncture - Moxibustion 2012; 22(2) doi: 10.1016/S1003-5257(12)60019-1
26
Philippe Chalaye, Philippe Goffaux, Patricia Bourgault, Sylvie Lafrenaye, Ghislain Devroede, Alain Watier, Serge Marchand. Comparing Pain Modulation and Autonomic Responses in Fibromyalgia and Irritable Bowel Syndrome Patients. The Clinical Journal of Pain 2012; 28(6) doi: 10.1097/AJP.0b013e31823ae69e
27
Ashish Chogle, Miguel Saps. Electrocardiograms changes in children with functional gastrointestinal disorders on low dose amitriptyline. World Journal of Gastroenterology 2014; 20(32): 11321-11325 doi: 10.3748/wjg.v20.i32.11321
28
Adrian Miranda, Miguel Saps. The Use of Non-Narcotic Pain Medication in Pediatric Gastroenterology. Pediatric Drugs 2014; 16(4) doi: 10.1007/s40272-014-0080-6
29
Dong-yun Chen, Lin Jia, Xi Gu, Shu-man Jiang, Hai-li Xie, Jian Xu. Comparison of paroxetine and amitriptyline in the treatment of refractory globus pharyngeus. Digestive and Liver Disease 2016; 48(9) doi: 10.1016/j.dld.2016.05.025
30
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi. The safety of novel drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Safety 2014; 13(5) doi: 10.1517/14740338.2014.902932
31
Taraneh Mousavi, Mohammadhossein Sharifnia, Shekoufeh Nikfar, Mohammad Abdollahi. Pharmacotherapy for gastric and intestinal cramping pain: ‎ current and emerging therapies. Expert Opinion on Pharmacotherapy 2023; 24(18) doi: 10.1080/14656566.2023.2265830
32
Yingcong Yu, Shujuan Wu, Jianxin Li, Renye Wang, Xupei Xie, Xuefeng Yu, Jianchun Pan, Ying Xu, Liang Zheng. The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling. Metabolic Brain Disease 2015; 30(1) doi: 10.1007/s11011-014-9554-z
33
Roy Dekel, Douglas A Drossman, Ami D Sperber. The use of psychotropic drugs in irritable bowel syndrome. Expert Opinion on Investigational Drugs 2013; 22(3) doi: 10.1517/13543784.2013.761205
34
Dawn A. Marcus, Atul Deodhar. Fibromyalgia. 2011;  doi: 10.1007/978-1-4419-1609-9_7
35
Michael Camilleri, Jan F. Tack. Current Medical Treatments of Dyspepsia and Irritable Bowel Syndrome. Gastroenterology Clinics of North America 2010; 39(3) doi: 10.1016/j.gtc.2010.08.005
36
J.M. Remes-Troche, E. Coss-Adame, M. Schmulson, K.R. García-Zermeño, M. Amieva-Balmori, R. Carmona-Sánchez, O. Gómez-Escudero, P.C. Gómez-Castaños, M.E. Icaza-Chávez, A. López-Colombo, E.C. Morel-Cerda, M.Á. Valdovinos-Díaz, L.R. Valdovinos-García, A.S. Villar-Chávez. Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024. Revista de Gastroenterología de México (English Edition) 2025; 90(1) doi: 10.1016/j.rgmxen.2024.10.009
37
Prashant Singh, Abhishek Agnihotri, Manish K Pathak, Asef Shirazi, Rajeew P Tiwari, V Sreenivas, Rajesh Sagar, Govind K Makharia. Psychiatric, Somatic and Other Functional Gastrointestinal Disorders in Patients With Irritable Bowel Syndrome at a Tertiary Care Center. Journal of Neurogastroenterology and Motility 2012; 18(3) doi: 10.5056/jnm.2012.18.3.324
38
Emeran A. Mayer, Hyo Jin Ryu, Ravi R. Bhatt. The neurobiology of irritable bowel syndrome. Molecular Psychiatry 2023; 28(4) doi: 10.1038/s41380-023-01972-w
39
Zhuo-Ying Tao, Pei-Xing Wang, Si-Qi Wei, Richard J. Traub, Jin-Feng Li, Dong-Yuan Cao. The Role of Descending Pain Modulation in Chronic Primary Pain: Potential Application of Drugs Targeting Serotonergic System. Neural Plasticity 2019; 2019 doi: 10.1155/2019/1389296
40
Agnieszka Kułak-Bejda, Grzegorz Bejda, Napoleon Waszkiewicz. Antidepressants for irritable bowel syndrome—A systematic review. Pharmacological Reports 2017; 69(6) doi: 10.1016/j.pharep.2017.05.014
41
Mudassir Alam, Kashif Abbas, Muskan Khan, Rakshit Singh Saini, Mohd Faraz. Irritable Bowel Syndrome: Clinical Manifestations, Pathological Insights, Diagnostic Methods and Effective Management Strategies. SN Comprehensive Clinical Medicine 2026; 8(1) doi: 10.1007/s42399-026-02317-8
42
Qiqing Sun, Nana Xiong, Yuwei Wang, Zhiwei Xia, Jie Chen, Chaogan Yan, Hongqiang Sun. Shared and distinct aberrations in frontal-striatal system functional patterns among patients with irritable bowel syndrome and major depressive disorder. Journal of Affective Disorders 2024; 362 doi: 10.1016/j.jad.2024.07.005
43
Bing Li, Li Liang, Huijie Deng, Jinmin Guo, He Shu, Li Zhang. Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00332
44
Merel M. Tielemans, Jeroen Jaspers Focks, Leo G. M. van Rossum, Ties Eikendal, Jan B. M. J. Jansen, Robert J. F. Laheij, Martijn G. H. van Oijen, Hamid Reza Baradaran. Gastrointestinal Symptoms are Still Prevalent and Negatively Impact Health-Related Quality of Life: A Large Cross-Sectional Population Based Study in The Netherlands. PLoS ONE 2013; 8(7) doi: 10.1371/journal.pone.0069876
45
Alexander M. Fassmer, Kathrin Wandscher, Aida Bedri, Kathrin Jobski, Luise Poustka, Christian J. Bachmann, Falk Hoffmann. Change of antidepressant utilization in children, adolescents and young adults in Europe before and during the COVID-19 pandemic: a systematic review. European Child & Adolescent Psychiatry 2026; 35(1) doi: 10.1007/s00787-025-02839-x
46
Eva Szigethy, Marc Schwartz, Douglas Drossman. Narcotic Bowel Syndrome and Opioid-Induced Constipation. Current Gastroenterology Reports 2014; 16(10) doi: 10.1007/s11894-014-0410-4
47
Diane E. Peters. Antidepressants for inflammatory bowel disease? Multimodal effects of amitriptyline in murine colitis. The Journal of Pharmacology and Experimental Therapeutics 2025; 392(3) doi: 10.1016/j.jpet.2024.103382
48
Chun-Yan Li, Shu-Chuen Li. Treatment of irritable bowel syndrome in China: A review. World Journal of Gastroenterology 2015; 21(8): 2315-2322 doi: 10.3748/wjg.v21.i8.2315
49
Melek B. Ozen, Isil Gazioglu, Ozden Ozgun Acar, Huseyin Guner, Gurkan Semiz, Alaattin Sen. Possible Drug-Drug Interactions Between Mesalamine and Tricyclic Antidepressants Through CYP2D6 Metabolism – In silico and In vitro Analyses. Drug Research 2025; 75(05) doi: 10.1055/a-2551-2418
50
Minahil Iqbal, Sara Hira, Humza Saeed, Sufyan Shahid, Suha T Butt, Kamran Rashid, Mohammad Ahmad, Hammad Hussain, Anzalna Mughal, Gabriel P A Costa, Fernanda Gushken, Neil Nero, Shreya Sengupta, Akhil Anand. Efficacy of Amitriptyline in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis. Journal of Neurogastroenterology and Motility 2025; 31(1) doi: 10.5056/jnm24084
51
Natasha A. Koloski, Nicholas J. Talley. Women and Health. 2026;  doi: 10.1016/B978-0-443-45863-7.00102-5
52
Barbara Pokora, Kacper Pokora, Jakub Fichna. Abdominal Pain. 2026;  doi: 10.1016/B978-0-443-41638-5.00005-3
53
Giulio Ongaro, Sarah Ballou, Tobias Kube, Julia Haas, Ted J. Kaptchuk. Doctors Speak: A Qualitative Study of Physicians’ Prescribing of Antidepressants in Functional Bowel Disorders. Culture, Medicine, and Psychiatry 2023; 47(3) doi: 10.1007/s11013-022-09795-0
54
Mohammad H Farzaei, Roodabeh Bahramsoltani, Mohammad Abdollahi, Roja Rahimi. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. Journal of Neurogastroenterology and Motility 2016; 22(4) doi: 10.5056/jnm16001
55
Uri Ladabaum, Erin Boyd, Wei K. Zhao, Ajitha Mannalithara, Annie Sharabidze, Gurkirpal Singh, Elaine Chung, Theodore R. Levin. Diagnosis, Comorbidities, and Management of Irritable Bowel Syndrome in Patients in a Large Health Maintenance Organization. Clinical Gastroenterology and Hepatology 2012; 10(1) doi: 10.1016/j.cgh.2011.08.015
56
Jan Juřica, Radek Kroupa. Pharmacotherapy of irritable bowel syndrome. Praktické lékárenství 2017; 13(2) doi: 10.36290/lek.2017.005
57
Ryan Ian Houe Chong, Clyve Yu Leon Yaow, Caitlin Yuen Ling Loh, Seth En Teoh, Yoshio Masuda, Wee Khoon Ng, Yu Liang Lim, Qin Xiang Ng. Vitamin D supplementation for irritable bowel syndrome: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2022; 37(6) doi: 10.1111/jgh.15852
58
Adesina Omoloye, Sabrina Weisenburger, Martin D. Lehner, Benjamin Gronier. Menthacarin treatment attenuates nociception in models of visceral hypersensitivity. Neurogastroenterology & Motility 2024; 36(4) doi: 10.1111/nmo.14760
59
Hossein Sadeghi, Valiolla Hajhashemi, Mohsen Minaiyan, Ahmad Movahedian, Ardeshir Talebi. Further studies on anti-inflammatory activity of maprotiline in carrageenan-induced paw edema in rat. International Immunopharmacology 2013; 15(3) doi: 10.1016/j.intimp.2013.01.018
60
Johanne L Agger, Andreas Schröder, Lise K Gormsen, Jens S Jensen, Troels S Jensen, Per K Fink. Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study. The Lancet Psychiatry 2017; 4(5) doi: 10.1016/S2215-0366(17)30126-8
61
Christoph Kowalewski, Ekkehard Haen, Christoph Hiemke, Florian Ridders, Katharina Endres, Gerhard Gründer, Michael Paulzen, Georgios Schoretsanitis. Cytochrome P450-mediated inhibition of venlafaxine metabolism by trimipramine. International Clinical Psychopharmacology 2019; 34(5) doi: 10.1097/YIC.0000000000000268
62
Maryam Ostovan, Seyyed Mohammad Bagher Fazljou, Hajar Khazraei, Mostafa Araj Khodaei, Mohammadli Torbati. <p>The Anti-Inflammatory Effect of Pistacia Lentiscus in a Rat Model of Colitis</p>. Journal of Inflammation Research 2020;  doi: 10.2147/JIR.S259035
63
Jan Tack, Tim Vanuytsel, Maura Corsetti. Modern Management of Irritable Bowel Syndrome: More Than Motility. Digestive Diseases 2016; 34(5) doi: 10.1159/000445265
64
Natasha Klemm, Sarvee Moosavi. Chronic Abdominal Pain in Patients with Inflammatory Bowel Disease in Remission: A Continuing Challenge for Clinicians. Digestive Diseases and Sciences 2024; 69(12) doi: 10.1007/s10620-024-08716-y
65
Nikul Bakshi, Ailsa L. Hart, Michael C. Lee, Amanda C de C. Williams, Jeffrey M. Lackner, Christine Norton, Peter Croft. Chronic pain in patients with inflammatory bowel disease. Pain 2021; 162(10) doi: 10.1097/j.pain.0000000000002304
66
Douglas Drossman, Eva Szigethy. The Narcotic Bowel Syndrome: A Recent Update. The American Journal of Gastroenterology Supplements 2014; 2(1) doi: 10.1038/ajgsup.2014.6
67
Tristan Carter, Joshua Z. Goldenberg, Amie Steel. An examination of naturopathic treatment of non-specific gastrointestinal complaints: comparative analysis of two cases. Integrative Medicine Research 2019; 8(3) doi: 10.1016/j.imr.2019.08.001
68
Sun Jung Oh, Will Takakura, Ali Rezaie. Shortcomings of Trials Assessing Antidepressants in the Management of Irritable Bowel Syndrome: A Critical Review. Journal of Clinical Medicine 2020; 9(9) doi: 10.3390/jcm9092933
69
Natasha A. Koloski, Nicholas J. Talley. Women and Health. 2013;  doi: 10.1016/B978-0-12-384978-6.00092-3
70
Wan-Tzu Lin, Yi-Jun Liao, Yen-Chun Peng, Chung-Hsin Chang, Ching-Heng Lin, Hong-Zen Yeh, Chi-Sen Chang. Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study. World Journal of Gastroenterology 2017; 23(19): 3513-3521 doi: 10.3748/wjg.v23.i19.3513
71
Erkki Kronholm, Juha Markkula, Lauri J. Virta. What is Behind the Seeming Cessation of the Increase in Sleep Medicine Consumption in Finland during the Last Years?. Journal of Public Health Research 2012; 1(2) doi: 10.4081/jphr.2012.e23
72
Miguel Saps, Naire Sansotta, Sean Bingham, Giuseppe Magazzu, Caterina Grosso, Simone Romano, Cenk Pusatcioglu, Stefano Guandalini. Abdominal Pain-Associated Functional Gastrointestinal Disorder Prevalence in Children and Adolescents with Celiac Disease on Gluten-Free Diet: A Multinational Study. The Journal of Pediatrics 2017; 182 doi: 10.1016/j.jpeds.2016.11.049
73
Grace C. Wester, Dominique M. Perilloux, Jolie A. Boullion, Caylin J. Roberts, Sahar Shekoohi, Alan David Kaye. New Opioid Receptor Modulators and Agonists. 2026;  doi: 10.1016/B978-0-443-26504-4.00002-8
74
Christopher V. Almario, Benjamin D. Noah, Alma Jusufagic, Daniel Lew, Brennan M.R. Spiegel. Cost Effectiveness of Biomarker Tests for Irritable Bowel Syndrome With Diarrhea: A Framework for Payers. Clinical Gastroenterology and Hepatology 2018; 16(9) doi: 10.1016/j.cgh.2018.03.025
75
J.M. Remes-Troche, E. Coss-Adame, M. Schmulson, K.R. García-Zermeño, M. Amieva-Balmori, R. Carmona-Sánchez, O. Gómez-Escudero, P.C. Gómez-Castaños, M.E. Icaza-Chávez, A. López-Colombo, E.C. Morel-Cerda, M.Á. Valdovinos-Díaz, L.R. Valdovinos-García, A.S. Villar-Chávez. Tratamiento farmacológico del síndrome de intestino irritable en México. Posicionamiento de la Asociación Mexicana de Gastroenterología 2024. Revista de Gastroenterología de México 2025; 90(1) doi: 10.1016/j.rgmx.2024.10.003
76
Ankita Wal, Pranay Wal, Neha Verma, Awani Kumar Rai, Piyush Vatsha. Mechanism, Pathophysiology and Herbal Management-A Review on Irritable Bowel Syndrome. The Natural Products Journal 2023; 13(3) doi: 10.2174/2210315512666220624163105
77
Tilak Shah, Alvin Zfass, Mitchell L. Schubert. Management of Sphincter of Oddi Dysfunction: Teaching an Old SOD New Tricks?. Digestive Diseases and Sciences 2016; 61(9) doi: 10.1007/s10620-016-4252-9
78
Qing Wu, Wenchun Qu, Michael D Crowell, Joseph G Hentz, Keith A Frey. Tricyclic antidepressant use and risk of fractures: A meta-analysis of cohort and case-control studies. Journal of Bone and Mineral Research 2013; 28(4) doi: 10.1002/jbmr.1813
79
Michael Camilleri, Emeran A. Mayer. Reply. Gastroenterology 2010; 138(2) doi: 10.1053/j.gastro.2009.12.039
80
Bernadette Schurink, Merel M. Tielemans, Bryan R.R.Z. Aaldering, Ties Eikendal, Jeroen Jaspers Focks, Robert J.F. Laheij, Jan B.M.J. Jansen, Leo G.M. van Rossum, Martijn G.H. van Oijen. Antidepressants and Gastrointestinal Symptoms in the General Dutch Adult Population. Journal of Clinical Psychopharmacology 2014; 34(1) doi: 10.1097/JCP.0000000000000055
81
Surya Prakash Mishra, Sunit Kumar Shukla, Bajrang Lal Pandey. A preliminary evaluation of comparative effectiveness of riluzole in therapeutic regimen for irritable bowel syndrome. Asian Pacific Journal of Tropical Biomedicine 2014; 4 doi: 10.12980/APJTB.4.2014C205
82
Michael Paulzen, Ekkehard Haen, Christoph Hiemke, Bianca Fay, Sandra Unholzer, Gerhard Gründer, Georgios Schoretsanitis. Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism. Journal of Affective Disorders 2018; 227 doi: 10.1016/j.jad.2017.11.046
83
Azar Asadi-Shahmirzadi, Shilan Mozaffari, Yara Sanei, Maryam Baeeri, Reza Hajiaghaee, Hamid Reza Monsef-Esfahani, Mohammad Abdollahi. Benefit of Aloe vera and Matricaria recutita mixture in rat irritable bowel syndrome: Combination of antioxidant and spasmolytic effects. Chinese Journal of Integrative Medicine 2012;  doi: 10.1007/s11655-012-1027-9
84
Jelena Šuran, Nikola Pavlović, Joško Božić, Marko Kumrić, Katarina Vukojević, Natalija Filipović, Božo Radić. IBS and SIBO: Gut Microbiota, Pathophysiology, and Non-Pharmacological Interventions. Antibiotics 2026; 15(3) doi: 10.3390/antibiotics15030251
85
Madhusudan Grover, Michael Camilleri. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. Journal of Gastroenterology 2013; 48(2) doi: 10.1007/s00535-012-0726-5
86
Rosanna Di Paola, Salvatore Cuzzocrea, Roberta Fusco, Marika Cordaro. Recent Developments in Antioxidants from Natural Sources. Biochemistry 2023; 41 doi: 10.5772/intechopen.109239
87
Zi Yu Liu, Xia Xu Gua, Rong Gui Zhang, Xiao Xiao Wang, Jie Ai, Wei Feng Wang, Yun Sheng Yang. Association of mitochondrial displacement loop polymorphisms with diarrhea‐predominant irritable bowel syndrome: A preliminary study. Journal of Digestive Diseases 2018; 19(5) doi: 10.1111/1751-2980.12597
88
Oliver Grundmann, Saunjoo L Yoon. Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health‐care practitioners. Journal of Gastroenterology and Hepatology 2010; 25(4) doi: 10.1111/j.1440-1746.2009.06120.x
89
Paul Enck, Florian Junne, Sibylle Klosterhalfen, Stephan Zipfel, Ute Martens. Therapy options in irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 2010;  doi: 10.1097/MEG.0b013e3283405a17
90
Rosa LS Soares. Irritable bowel syndrome: A clinical review. World Journal of Gastroenterology 2014; 20(34): 12144-12160 doi: 10.3748/wjg.v20.i34.12144
91
Asieh Hosseini, Shekoufeh Nikfar, Mohammad Abdollahi. Probiotics use to treat irritable bowel syndrome. Expert Opinion on Biological Therapy 2012; 12(10) doi: 10.1517/14712598.2012.707179
92
Qing Wu, Yingke Xu, Yueyang Bao, Jovan Alvarez, Mikee Lianne Gonzales. Tricyclic Antidepressant Use and Risk of Fractures: A Meta-Analysis of Cohort Studies through the Use of Both Frequentist and Bayesian Approaches. Journal of Clinical Medicine 2020; 9(8) doi: 10.3390/jcm9082584
93
Peter Henningsen, Stephan Zipfel, Heribert Sattel, Francis Creed. Management of Functional Somatic Syndromes and Bodily Distress. Psychotherapy and Psychosomatics 2018; 87(1) doi: 10.1159/000484413
94
Arvind Iyengar Srinath, Chelsea Walter, Melissa C. Newara, Eva M. Szigethy. Pain management in patients with inflammatory bowel disease: insights for the clinician. Therapeutic Advances in Gastroenterology 2012; 5(5) doi: 10.1177/1756283X12446158
95
Mahsa Moeinian, Amir Hossein Abdolghaffari, Shekoufeh Nikfar, Saeideh Momtaz, Mohammad Abdollahi. Effects of alpha lipoic acid and its derivative “andrographolid‐lipoic acid‐1” on ulcerative colitis: A systematic review with meta‐analysis of animal studies. Journal of Cellular Biochemistry 2019; 120(4) doi: 10.1002/jcb.27807
96
Hye In Kim, Sung-Ae Jung, Ju Young Choi, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim, Kwon Yoo. Impact of Shiftwork on Irritable Bowel Syndrome and Functional Dyspepsia. Journal of Korean Medical Science 2013; 28(3) doi: 10.3346/jkms.2013.28.3.431
97
Adam D. Farmer, Madusha Peiris, Qasim Aziz. Irritable Bowel Syndrome. 2013;  doi: 10.1002/9781118444689.ch12
98
Miguel Saps, Harman S. Biring, Cenk K. Pusatcioglu, Stijn Mintjens, Damian Rzeznikiewiz. A Comprehensive Review of Randomized Placebo‐Controlled Pharmacological Clinical Trials in Children With Functional Abdominal Pain Disorders. Journal of Pediatric Gastroenterology and Nutrition 2015; 60(5) doi: 10.1097/MPG.0000000000000718
99
Richard A. Schatz, Baharak Moshiree. Gastrointestinal and Hepatic Disease in Fibromyalgia. Rheumatic Disease Clinics of North America 2018; 44(1) doi: 10.1016/j.rdc.2017.09.009
100
Hossein Sadeghi, Valiolla Hajhashemi, Mohsen Minaiyan, Ahmad Movahedian, Ardeshir Talebi. A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats. European Journal of Pharmacology 2011; 667(1-3) doi: 10.1016/j.ejphar.2011.05.053
101
Kate Seaton, Alannah Quinlivan, Nava Ferdowsi, Wendy Stevens, Chamara Basnayake, Laura Ross. Quantifying the Prevalence of Disorders of Gut Brain Interaction in Systemic Sclerosis. Neurogastroenterology & Motility 2026; 38(2) doi: 10.1111/nmo.70254
102
Rajan Singh, Hannah Zogg, Uday C Ghoshal, Seungil Ro. Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.808195
103
Stefanie L. Y. Cheung, Leanne C. Kenway, Maharshi Bhaswant. Pathophysiological Mechanisms and Nonpharmacological Interventions in Irritable Bowel Syndrome: Current Insights and Future Directions. Journal of Nutrition and Metabolism 2026; 2026(1) doi: 10.1155/jnme/4520019
104
Matthew D Coates, Kofi Clarke, Emmanuelle Williams, Nimalan Jeganathan, Sanjay Yadav, David Giampetro, Vitaly Gordin, Sadie Smith, Kent Vrana, Anne Bobb, Thu Thi Gazzio, Heather Tressler, Shannon Dalessio. Abdominal Pain in Inflammatory Bowel Disease: An Evidence-Based, Multidisciplinary Review. Crohn's & Colitis 360 2023; 5(4) doi: 10.1093/crocol/otad055
105
Tina Didari, Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology 2015; 21(10): 3072-3084 doi: 10.3748/wjg.v21.i10.3072
106
Marinos Fysekidis, Michel Bouchoucha, Hélène Bihan, Gérard Reach, Robert Benamouzig, Jean-Marc Catheline. Prevalence and Co-occurrence of Upper and Lower Functional Gastrointestinal Symptoms in Patients Eligible for Bariatric Surgery. Obesity Surgery 2012; 22(3) doi: 10.1007/s11695-011-0396-z
107
Paolo Quitadamo, Sara Isoldi, Saverio Mallardo, Letizia Zenzeri, Giovanni Di Nardo. Scientific Evidence for the Treatment of Children with Irritable Bowel Syndrome. Current Pediatric Reviews 2021; 17(2) doi: 10.2174/1573396317666210127123330